Concord Drugs Ltd.

CONCORD

₹84.45

1.44% (1.2)

Market Cap

₹111 Cr.

P/E

196.58

Key Ratios

Edit Ratio's

Market cap

111 Cr

196

Prom Holding

54.39 %

ROE (%)

0.99

ROCE (%)

6.98

Div Yield (%)

Sales

51.27 Cr

OPM (%)

8.01 %

Debt to Equity

0.56

Edit Ratio's

About

Concord Drugs Limited, established in 1995, focuses on manufacturing and marketing innovative … Read more

Low

52W Range

High

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

New

Edit rows

Forensics

6 Yes

Positive for this company

1 Neutral

Neutral for this company

9 No

Negative for this company

1 No Data

Insufficient data to analyse

Accounting & Shareholding

Depreciation Effect

Depreciation accounting is not leading to increase in profits
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Revenue Recognition

Company is converting accounting profit to cash
Promoter Holding

Promoter has not sold any shares in the last 90 days
Retail Holding

Retail has been buying the stock which is usually a sign of exuberance
Contingent Liabilities

Unable to calculate due to limited data

Price & Performance

ROE

Asset turnover is responsible for roe increase over last 10 years
Balance Sheet Strength

Balance sheet of the company is strong. it shouldnt have solvency or liquidity issues
Capex vs ROCE

Roce of the company has decreased even without significant capex
Current vs Historic Valuation

Company is trading at a premium to 3yr historic valuations
Debt

Company might have issues servicing its debt
Share price

Share price has increased over last 10 years but more due to rerating
Working Capital

Company has significant working capital which is dragging its roce and roe
Sales Growth

Sales of the company has grown at a slow pace
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong

Revenue mix

Product Wise Break-Up

Peer Comparison

FAQs on Concord Drugs Ltd. Business

What does Concord Drugs do?

Concord Drugs Limited, founded in 1995, is a leading pharmaceutical company in India. Specializing in generics, branded, and specialty pharmaceuticals, Concord is known for its diverse product portfolio of over 200 prescription and over-the-counter products.

Who are the competitors of Concord Drugs?

Concord Drugs major competitors are Denis Chem Lab, Vijaypd Ceutical, Vaishali Pharma, Mercury Laboratories, Lactose India, Pharmaids Pharma, Tyche Inds.
Market Cap of Concord Drugs is ₹110 Crs.
While the median market cap of its peers are ₹119 Crs.

Is Concord Drugs financially stable compared to its competitors?

Concord Drugs seems to be less financially stable compared to its competitors.
Altman Z score of Concord Drugs is 3.8 and is ranked 4 out of its 8 competitors.

View FAQ's On Shareprice

Company Filing

	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Ideas Dashboard

Results

Timeline

Watchlist

Portfolio

Alerts

Stock Screener

Market

Raw Material

Concord Drugs Ltd.

Concord Drugs Ltd.

Key Ratios

About

Timeline

Company Timeline

Custom financial statement

Forensics

6 Yes

1 Neutral

9 No

1 No Data

Accounting & Shareholding

Depreciation Effect

Other Income

Pledge

Revenue Recognition

Promoter Holding

Retail Holding

Contingent Liabilities

Price & Performance

ROE

Balance Sheet Strength

Capex vs ROCE

Current vs Historic Valuation

Debt

Share price

Working Capital

Sales Growth

Margin Stability

ROCE Strength

Revenue mix

Product Wise Break-Up

UNLOCK PREMIUM

Peer Comparison

FAQs on Concord Drugs Ltd. Business

What does Concord Drugs do?

Who are the competitors of Concord Drugs?

Is Concord Drugs financially stable compared to its competitors?

Company Filing

Discussions & Analysis

SIGN UP FOR FREE